Form 10-Q AtriCure, Inc. For: Jun 30

Go back to Form 10-Q AtriCure, Inc. For: Jun 30

BTIG Trims PT on AtriCure (ATRC) to $19; Management 'Disconnect' Causes Concern

August 8, 2016 11:17 AM EDT

BTIG cut its price target on Buy-rated AtriCure (NASDAQ: ATRC) from $34 down to $19 after the company reported Q2 results late last week.

Analyst Sean Lavin commented, ATRC reported a relatively in-line but messy quarter with the core business coming in soft while increased focus on nContact... More